-transparent.png){kind=logo}
We studied the hypoproliferative response of synovial fluid (SF) T cells in rheumatoid arthritis (RA) using a mitogenic monoclonal antibody (MoAb) specific for the T-cell antigen receptor-associated CD3 complex. RASF T cells are defective in their proliferative response and in the induction of the Tac (p55) component of the IL-2-receptor (IL-2-R) when stimulated with anti-CD3 monoclonal antibody (MoAb). However, fresh RASF T cells bear demonstrable IL-2-R in cross-linking experiments which are not seen in unstimulated peripheral blood (PB). These receptors are functional since RASF T cells proliferate in response to recombinant IL-2 (rIL-2) better than fresh PB T cells from either normal or RA patients. Scatchard analysis indicates increased (4-fold) numbers of high affinity IL-2-R on (phytohaemagglutinin) PHA-activated RASF T cells as compared with comparably activated RAPB T cells. Phorbol myristate acetate (PMA) induces Tac antigen expression in RASF but does not lead to proliferation. The hyporesponsiveness of RASF T cells does not appear to result from lack of IL-2-R, lack of IL-2-R inducibility, or proliferative potential.
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
March 1995,
The Journal of rheumatology,
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
June 1986,
Clinical and experimental immunology,
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
August 2012,
Journal of clinical immunology,
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
January 1987,
Rheumatology international,
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
January 1993,
Clinical and experimental immunology,
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
July 1995,
Annals of the New York Academy of Sciences,
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
January 1979,
Bollettino dell'Istituto sieroterapico milanese,
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
April 1986,
Clinical and experimental immunology,
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
August 1996,
Arthritis and rheumatism,
M J Dauphinée, and
H Dang, and
E Flescher, and
K Wilson-Burris, and
D Galarza, and
K Hempel, and
N Talal
April 1987,
The Journal of rheumatology,
